Home / Inspections / 1323692

FDA Inspection 1323692 — Roche Molecular Systems, Inc.

Roche Molecular Systems, Inc. — FEI 2243471

The FDA completed an inspection of Roche Molecular Systems, Inc. on June 12, 2026 in Branchburg, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 12, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Branchburg, NJ (United States)

Facility

Other inspections at this facility

  • 1224711 (VAI Fri Dec 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1100926 (NAI Wed Jul 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1027092 (NAI Mon Jul 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1020421 (VAI Wed Jul 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 979955 (NAI Wed Jul 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources